Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia

Phase III Study Priming With rhu_GM-CSF and of Three Induction Regimens in Adult Patients (55 and Over) With Acute Non-Lymphocytic Leukemia

NCT04446052•Eastern Cooperative Oncology Group

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia

Interventions

GM-CSF priming

Placebo

Key Dates

Start Date

May 21, 1993

Primary Completion Date

July 10, 2002

Completion Date

July 10, 2002

Last Updated

June 22, 2023

Sponsors

Lead Sponsor

Eastern Cooperative Oncology Group

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 22, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions